April 9, 2015 | Hotel Sarovar, Baddi, Himachal Pradesh, India
Apr. 9, 2015, Hotel Sarovar, Baddi, Himachal Pradesh, India
Baddi is home to some of the most renowned pharmaceutical and electrical industries in India. The widespread industrial cluster of Baddi is one of the major factors spearheading India’s growth in pharma and electrical sectors. However, inadequate or poor quality systems implementation, data integrity issues, inadequate validation of various processes used in manufacturing, testing and product adulteration or contamination (source: http://bit.ly/1Dn7q6Q) are some of the issues that needs to be addressed by the Indian pharma and electrical industry.
UL in India’s commitment to offer critical testing, consulting and research services helps ensure safer and more productive products in the global market. This expertise will help mitigate the existing challenges of the pharmaceuticals and electricals industries in Baddi.
UL, in association with Baddi Barotiwala Nalagarh Industries Association (BBNIA), will organize a day-long technical seminar for the Electricals and Pharmaceuticals Industry to address some of these challenges and help meet current regulatory requirements globally.
The seminar is aimed to provide informative and robust strategies for standardization of products that are relevant for U.S. and European directives and standards. The discussion will include topics like GMP, FDA and BIS regulations. In addition to this, it will provide industry-specific insights that help meet export requirements, and position and sell products in multiple countries.
For the Electricals industry, the technical sessions will focus:
The discussions on the Pharmaceuticals industry will look into issues like:
Our trusted reputation can provide a key quality differentiator for pharmaceutical products. Our combination of educational resources, technologies and services provides a robust and cost-effective solution that enables enterprise-wide knowledge transfer and facilitates compliance with U.S. and global regulatory agencies and organizations, including the FDA, EMEA, ICH and ISO.